Gut Microbiome in Inflammatory Bowel Disease
Discovery of Gut Microbial Signatures in Inflammatory Bowel Disease
Kyunghee University Medical Center
1,500 participants
Apr 1, 2018
OBSERVATIONAL
Conditions
Summary
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity. In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.
Eligibility
Inclusion Criteria1
- Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
Exclusion Criteria1
- Person with history of using antibiotics or probiotics within previous 2 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03589183